S 2238: chromogenic substrate for thrombin; used in amidolytic assay; patterned after N-terminal portion of A alpha chain of fibrinogen; synonym S-2238 refers to di-HCl
ID Source | ID |
---|---|
PubMed CID | 123853 |
MeSH ID | M0075603 |
Synonym |
---|
d-phe-pip-arg-pna |
s 2238 |
(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]piperidine-2-carboxamide |
64815-81-2 |
chromogenic substrate s-2238 |
h-d-phenylalanyl-l-pipecolyl-arginine-nitroanilide |
h-d-phenylalanyl-pip-arg-p-nitroanilide |
d-phenylalanyl-l-2-piperidinecarbonyl-n-(4-nitro phenyl)-l-argininamide |
h-d-phe-pip-arg-pna |
h-phe-pip-arg-p-nitroanilide |
h-phe-pip-arg-pna |
s-2238 |
bdbm12678 |
n-(4-nitrophenyl)-n2-{[(2s)-1-d-phenylalanylpiperidin-2-yl]carbonyl}-l-argininamide |
(2s)-2-{[(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]piperidin-2-yl]formamido}-5-carbamimidamido-n-(4-nitrophenyl)pentanamide |
h-d-phenylalanyl-l-pipecolyl-l-arginine-p-nitroaniline dihydrochloride |
bdbm233013 |
YDMBNDUHUNWWRP-VJBWXMMDSA-N |
n-[5-carbamimidamido-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-phenylalanylpiperidine-2-carboximidic acid |
DTXSID50983410 |
(s)-1-(d-phenylalanyl)-n-((s)-5-guanidino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)piperidine-2-carboxamide |
HY-123275 |
CS-0082307 |
AKOS040753879 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 44 (46.81) | 18.7374 |
1990's | 29 (30.85) | 18.2507 |
2000's | 16 (17.02) | 29.6817 |
2010's | 4 (4.26) | 24.3611 |
2020's | 1 (1.06) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (1.05%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 94 (98.95%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
New modified activated partial thromboplastin time and prothrombin time methods using a synthetic chromogenic substrate in combination with diazotization. Thrombosis research, Apr-15, Volume: 46, Issue: 2 | 1987 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |